Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114938) titled 'Pucotenlimab Combined with Concurrent Chemoradiotherapy as Neoadjuvant Therapy for Microsatellite Stable (MSS) Locally Advanced Rectal Cancer' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
Locally Advanced Rectal Cancer
Intervention:
Control Group:Neoadjuvant Chemoradiotherapy
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-12-22
Target Sample Size: Control Group:70;Intervention Group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/s...